Header cover image

U.K. Pharmaceuticals & Biotech Sustainable Track Record

Results

2

0 new

Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.

2 companies

AstraZeneca

Market Cap: UK£231.4b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

AZN

UK£149.18

7D

-0.3%

1Y

45.1%

HUTCHMED (China)

Market Cap: UK£1.9b

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.

HCM

UK£2.22

7D

0%

1Y

1.8%